HR Execs on the Move

ThromboGenics

www.thrombogenics.com

 
ThromboGenics is an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic and oncology medicines. The Company`s lead product, JETREA® (ocriplasmin), has been approved by the US FDA for the treatment of symptomatic VMA and was launched in January 2013. ThromboGenics signed a strategic partnership with Alcon, a division of Novartis, for the commercialization of JETREA® outside the United States. ThromboGenics is headquartered in Leuven, Belgium, and has offices in Iselin, NJ (US) and Dublin, Ireland. The Company is listed on the NYSE Euronext Brussels exchange under the symbol THR.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Carondelet Medical Group

Carondelet Medical GroupPatient Centered Care, Experienced Medical ExcellenceThe Carondelet team is here to provide exceptional, patient-centered medical care for the entire family. From routine check-ups to chronic disease management to healing from a...

Direct Biologics

Premier Research

Premier Research is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

ABO Pharmaceuticals

ABO Pharmaceuticals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Columbus Prescription Pharmacies

Columbus Prescription Pharmacies, Inc. is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.